Nuvectis Pharma, Inc. Quarterly Return On Assets in % from Q3 2022 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Nuvectis Pharma, Inc. quarterly/annual Return On Assets history and growth rate from Q3 2022 to Q3 2024.
  • Nuvectis Pharma, Inc. Return On Assets for the quarter ending September 30, 2024 was -104 %, a 2.41% increase year-over-year.
  • Nuvectis Pharma, Inc. annual Return On Assets for 2023 was -108 %, a 8.91% decline from 2022.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -104 +2.57 +2.41% Jul 1, 2024 Sep 30, 2024
Q2 2024 -106 -2.87 -2.78% Apr 1, 2024 Jun 30, 2024
Q1 2024 -104 +2.69 +2.52% Jan 1, 2024 Mar 31, 2024
Q4 2023 -108 -8.82 -8.91% Oct 1, 2023 Dec 31, 2023
Q3 2023 -107 -14.1 -15.3% Jul 1, 2023 Sep 30, 2023
Q2 2023 -103 Apr 1, 2023 Jun 30, 2023
Q1 2023 -107 Jan 1, 2023 Mar 31, 2023
Q4 2022 -99 Oct 1, 2022 Dec 31, 2022
Q3 2022 -92.5 Jul 1, 2022 Sep 30, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.